-
Something wrong with this record ?
Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin
D. Šimčíková, D. Gardáš, K. Hložková, M. Hruda, P. Žáček, L. Rob, P. Heneberg
Language English Country Great Britain
Document type Journal Article
Grant support
324421
Grantová Agentura, Univerzita Karlova
1428218
Grantová Agentura, Univerzita Karlova
260531/SVV/2020
Univerzita Karlova v Praze
NLK
BioMedCentral
from 2013-01-12
BioMedCentral Open Access
from 2013
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2015-01-01
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2013-01-01
Health & Medicine (ProQuest)
from 2015-01-01
Health Management Database (ProQuest)
from 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
Springer Nature OA/Free Journals
from 2013-12-01
- Publication type
- Journal Article MeSH
BACKGROUND: Hexokinases (HKs) are well-studied enzymes catalyzing the first step of glycolysis. However, non-canonical regulatory roles of HKs are still incompletely understood. Here, we hypothesized that HKs comprise one of the missing links between high-dose metformin and the inhibition of the respiratory chain in cancer. METHODS: We tested the isoenzyme-specific regulatory roles of HKs in ovarian cancer cells by examining the effects of the deletions of HK1 and HK2 in TOV-112D ovarian adenocarcinoma cells. We reverted these effects by re-introducing wild-type HK1 and HK2, and we compared the HK1 revertant with the knock-in of catalytically dead HK1 p.D656A. We subjected these cells to a battery of metabolic and proliferation assays and targeted GC×GC-MS metabolomics. RESULTS: We found that the HK1 depletion (but not the HK2 depletion) sensitized ovarian cancer cells to high-dose metformin during glucose starvation. We confirmed that this newly uncovered role of HK1 is glycolysis-independent by the introduction of the catalytically dead HK1. The expression of catalytically dead HK1 stimulated similar changes in levels of TCA intermediates, aspartate and cysteine, and in glutamate as were induced by the HK2 deletion. In contrast, HK1 deletion increased the levels of branched amino acids; this effect was completely eliminated by the expression of catalytically dead HK1. Furthermore, HK1 revertants but not HK2 revertants caused a strong increase of NADPH/NADP ratios independently on the presence of glucose or metformin. The HK1 deletion (but not HK2 deletion) suppressed the growth of xenotransplanted ovarian cancer cells and nearly abolished the tumor growth when the mice were fed the glucose-free diet. CONCLUSIONS: We provided the evidence that HK1 is involved in the so far unknown glycolysis-independent HK1-metformin axis and influences metabolism even in glucose-free conditions.
3rd Faculty of Medicine Charles University Ruská 87 CZ 100 00 Prague Czech Republic
CLIP Childhood Leukaemia Investigation Prague Prague Czech Republic
Faculty of Science BIOCEV Charles University Vestec Czech Republic
University Hospital Kralovské Vinohrady Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001060
- 003
- CZ-PrNML
- 005
- 20220112153452.0
- 007
- ta
- 008
- 220107s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s40170-021-00277-2 $2 doi
- 035 __
- $a (PubMed)34895333
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Šimčíková, Daniela $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic
- 245 10
- $a Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin / $c D. Šimčíková, D. Gardáš, K. Hložková, M. Hruda, P. Žáček, L. Rob, P. Heneberg
- 520 9_
- $a BACKGROUND: Hexokinases (HKs) are well-studied enzymes catalyzing the first step of glycolysis. However, non-canonical regulatory roles of HKs are still incompletely understood. Here, we hypothesized that HKs comprise one of the missing links between high-dose metformin and the inhibition of the respiratory chain in cancer. METHODS: We tested the isoenzyme-specific regulatory roles of HKs in ovarian cancer cells by examining the effects of the deletions of HK1 and HK2 in TOV-112D ovarian adenocarcinoma cells. We reverted these effects by re-introducing wild-type HK1 and HK2, and we compared the HK1 revertant with the knock-in of catalytically dead HK1 p.D656A. We subjected these cells to a battery of metabolic and proliferation assays and targeted GC×GC-MS metabolomics. RESULTS: We found that the HK1 depletion (but not the HK2 depletion) sensitized ovarian cancer cells to high-dose metformin during glucose starvation. We confirmed that this newly uncovered role of HK1 is glycolysis-independent by the introduction of the catalytically dead HK1. The expression of catalytically dead HK1 stimulated similar changes in levels of TCA intermediates, aspartate and cysteine, and in glutamate as were induced by the HK2 deletion. In contrast, HK1 deletion increased the levels of branched amino acids; this effect was completely eliminated by the expression of catalytically dead HK1. Furthermore, HK1 revertants but not HK2 revertants caused a strong increase of NADPH/NADP ratios independently on the presence of glucose or metformin. The HK1 deletion (but not HK2 deletion) suppressed the growth of xenotransplanted ovarian cancer cells and nearly abolished the tumor growth when the mice were fed the glucose-free diet. CONCLUSIONS: We provided the evidence that HK1 is involved in the so far unknown glycolysis-independent HK1-metformin axis and influences metabolism even in glucose-free conditions.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gardáš, Dominik $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic
- 700 1_
- $a Hložková, Kateřina $u CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Hruda, Martin $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Žáček, Petr $u Faculty of Science, BIOCEV, Charles University, Vestec, Czech Republic
- 700 1_
- $a Rob, Lukáš $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic $u University Hospital Kralovské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Heneberg, Petr $u Third Faculty of Medicine, Charles University, Ruská 87, CZ-100 00, Prague, Czech Republic. petr.heneberg@lf3.cuni.cz
- 773 0_
- $w MED00208612 $t Cancer & metabolism $x 2049-3002 $g Roč. 9, č. 1 (2021), s. 41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34895333 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153448 $b ABA008
- 999 __
- $a ind $b bmc $g 1745345 $s 1152207
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 9 $c 1 $d 41 $e 20211211 $i 2049-3002 $m Cancer & metabolism $n Cancer Metab $x MED00208612
- GRA __
- $a 324421 $p Grantová Agentura, Univerzita Karlova
- GRA __
- $a 1428218 $p Grantová Agentura, Univerzita Karlova
- GRA __
- $a 260531/SVV/2020 $p Univerzita Karlova v Praze
- LZP __
- $a Pubmed-20220107